Although rare, loss-of-function mutations in the cadherin superfamily member FAT1 [95] have also been associated with CDK4/6is resistance, potentially due to CDK6 overexpression in ER+ breast cancer patients [80]. This evidence concerns the gene ESR1 and breast cancer.